`
`CASE PAT030731-US-CNT03
`
`ART UNIT: 1624
`
`EXAMINER: KIFLE, BRUCK
`
`CONF. NO.: 7112
`
`IN REAPPLICATION OF
`
`NAVARRO, FRAN<;OIS ET AL.
`
`APPLICATION NO: 12/497728
`
`FILED: JULY 06, 2009
`
`FOR: MACROLIDES
`
`MS: Issue Fee
`Commissioner for Patents
`PO Box 1450
`Alexandria, VA 22313-1450
`
`AMENDMENT AFTER ALLOWANCE UNDER 37 CFR §1.312(a)
`
`Sir:
`
`2010.
`
`This Amendment is submitted in response to the Notice of Allowance mailed January 13,
`
`Amendments to the Claims are reflected in the listing of the claims which begins on
`
`page 2 of this paper.
`
`Remarks/Arguments begin on page 3 of this paper.
`
`1
`
`
`
`Amendments to the Claims:
`
`This listing of claims will replace all prior versions, and listings, of claims in the
`
`application:
`
`Listing of Claims:
`
`Claim 1. (Original): A solid mixture comprising 40-0-(2-hydroxy)ethyl-rapamycin and 2,6-di-tert(cid:173)
`
`butyl-4-methylphenol (BHT).
`
`Claim 2. (Original): A mixture according to claim 1, wherein said 2,6-di-tert-butyl-4-
`
`methylphenol (BHT) is present in a catalytic amount.
`
`Claim 3. (New): A pharmaceutical composition comprising the solid mixture of claim 1.
`
`-2-
`
`2
`
`
`
`Remarks/Arguments
`
`Applicants wish to thank the Office and Examiner Kifle for the Notice of Allowance mailed
`
`January 13, 2010. Applicants provide the instant amendment after allowance in order to add a
`
`new dependent pharmaceutical composition claim (new claim 3). This claim finds support in the
`
`originally filed application at page 4. Therefore, no new matter has been added by way of this
`
`amendment.
`
`New claim 3 should have been filed along with the original (and allowed) claims 1-2.
`
`However, due to Applicants oversight, only claims 1-2 were presented. Applicants apologize for
`
`the inconvenience to the Office.
`
`Novartis Pharmaceuticals Corporation
`One Health Plaza, Bldg. 101
`East Hanover, NJ 07936
`(862) 778-9308
`
`Date: 1/u /l o
`
`eslie Fischer
`Attorney for Applicant
`Reg. No. 58,393
`
`-3-
`
`3